In a 13G filing on Oncomed Pharmaceuticals (Nasdaq: OMED), Celgene Corp (Nasdaq: CELG) disclosed a 5.00%, or 1,470,588 share, stake ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE